22297 Hamburg, de
+49 (40) 5555090-3040
Senvion announces agreement with its lenders as it continues its accelerated M&A process
Senvion concludes agreement with its lenders which gives sufficient financial support until at least end of August
M&A process further accelerated in order to achieve results soon
All business areas under review
Senvion today announced that it has reached an agreement with its lenders which gives financial support for the continuation of its business until the end of August and potentially for a period thereafter if ongoing talks with lenders can be concluded successfully. This agreement enables Senvion to further accelerate its M&A process in order to achieve results soon. Discussions with potential bidders are at an advanced stage.
Yves Rannou, CEO of Senvion, said: "In tandem with the hard work and commitment of everybody at Senvion, we have been exploring our options to secure the best possible outcome for the company. However, as negotiations have not yet been concluded, we will further accelerate the M&A process and in parallel initiate a review of all business areas to secure Senvion's profitable core business. The goal is to finalise our advanced investor discussions in the short term. I am grateful for all the support of our dedicated employees and would like to thank our lenders for their continued financial support."
As a contingency for an unsuccessful outcome to the company's efforts to sell Senvion as a whole, or substantial parts of it, the management has to prepare for all eventualities. To this end, management will shortly be meeting with employees' representatives to begin the negotiations regarding social plans and balance of interest schemes for all business areas or substantial parts of it if an investor cannot be found in time.
The use of information published here for personal information and editorial processing is generally free of charge. Please clarify any copyright issues with the stated publisher before further use. In the event of publication, please send a specimen copy to firstname.lastname@example.org.